Dianthus Therapeutics | MGTA - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.01M 153K 2026-03
Avita Medical AUD -11.62M 1.7M 2025-12
Celltrion KRW 8.82B 64.74M 2026-03
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 9.02B 1.51B 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Moderna USD -1.34B 517M 2026-03
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD -921K 20.89M 2026-03
Organon & Co USD 146M 351M 2026-03
Ovoca Bio EUR 4.42M 5.19M 2025-12
Pharma Mar EUR -972K 2.5M 2026-06
Qiagen NV USD 68.04M 39.79M 2026-03
Revvity USD 51.82M 11.1M 2026-06
Sartorius EUR 65.9M 9.7M 2026-06
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Tilray USD -44.93M 44.61M 2025-09
Viatris USD -118.8M 295.2M 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zealand Pharma A/S -394M 14.88M 2026-03
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03